2020
DOI: 10.1097/pgp.0000000000000670
|View full text |Cite
|
Sign up to set email alerts
|

Secretory Carcinoma (Mammary Analogue Secretory Carcinoma) of the Vulva With ETV6 Gene Rearrangement: A Brief Report With Follow-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…8,9 While ETV6::NTRK3 fusion has not been described in any other salivary gland tumors, it is shared with SCs in other anatomic sites including the breast, 2 lacrimal gland, 10 thyroid gland, 11,12 skin, [13][14][15][16] sinonasal tract, 17,18 lung, 19 and vulva. 20,21 Still, this fusion is not SC specific, as it is identified in infantile fibrosarcoma, 22 congenital mesoblastic nephroma, 23 hematopoietic malignancies, 24 ALK-negative inflammatory myofibroblastic tumor, 25 gastrointestinal stromal tumor, 26 papillary thyroid carcinoma, 27 and many other entities throughout the body.…”
mentioning
confidence: 99%
“…8,9 While ETV6::NTRK3 fusion has not been described in any other salivary gland tumors, it is shared with SCs in other anatomic sites including the breast, 2 lacrimal gland, 10 thyroid gland, 11,12 skin, [13][14][15][16] sinonasal tract, 17,18 lung, 19 and vulva. 20,21 Still, this fusion is not SC specific, as it is identified in infantile fibrosarcoma, 22 congenital mesoblastic nephroma, 23 hematopoietic malignancies, 24 ALK-negative inflammatory myofibroblastic tumor, 25 gastrointestinal stromal tumor, 26 papillary thyroid carcinoma, 27 and many other entities throughout the body.…”
mentioning
confidence: 99%